(MedPage Today) — Treatment with the supplement berberine failed to reduce visceral adipose tissue or liver fat in adults with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), a randomized trial from China found….
Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/119460
Author :
Publish date : 2026-01-16 16:00:00
Copyright for syndicated content belongs to the linked Source.
